Existing anticancer therapeutics exhibit short half-lives, non-specificity, and severe side
effects. To address this, active-targeting nanoparticles have been developed; however, the …

Although activin receptor IIB (ACVR2B) is emerging as a novel pathogenic receptor, its
ligand and assembled components (or assembly) are totally unknown in the context of …

Articular cartilage injury is one of the most common diseases in orthopedic clinics. Following
an articular cartilage injury, an inability to resist vascular invasion can result in cartilage …

Emerging techniques of additive manufacturing, such as vat-based three-dimensional (3D)
bioprinting, offer novel routes to prepare personalized scaffolds of complex geometries …

Mitochondrial dysfunction increases ROS production and is closely related to many
degenerative cellular organelle diseases. The NOX4-p22phox axis is a major contributor to …

The multiple enzymatic properties of the Au3+-modified metal–organic framework (Au3+-
MOFs) have made it a functional catalytic system for antitumor treatment. However, in the …

Background and Purpose The discovery of new bromo‐and extra‐terminal inhibitors
presents new drugs to treat osteoarthritis (OA). Experimental Approach The new drug …

Tagetes erecta and Ocimum basilicum are medicinal plants that exhibit anti-inflammatory
effects against various diseases. However, their individual and combined effects on …

In the pharmaceutical formulation of anticancer drugs, US FDA-approved cyclodextrin (CD)
and its derivates have been widely employed. Among them, hydroxypropyl β-cyclodextrin …